Roy Moncayo - Concepedia

Author

Roy Moncayo

Also Known As

Moncayo R, R Moncayo, R. MONCAYO, R. Moncayo, R.C. Moncayo, ROY MONCAYO, Rodrigo Hernandez Moncayo, Rodrigo Hérnandez Moncayo, Roy Moncayo, Roy-Cesar Moncayo

177

Publications

3.9K

Citations

H-Index

135

Concepts

All Affiliations

Universität Innsbruck Innsbruck Medical University Universität Ulm University Hospital Innsbruck Zentralklinik Bad Berka

About

Roy Moncayo is an author at Universität Innsbruck specializing in medicine, radiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	32	1.5K
2	Health Sciences	17	17	1.3K
3	Engineering	7	7	489
4	Language Studies	1	1	19
5	Natural Sciences	1	1	38

Roy Moncayo

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging Emilio Bombardieri, Francesco Giammarile, Cumali Aktolun, European Journal of Nuclear Medicine and Molecular Imaging Oncologic ImagingMedical ImagingProcedure GuidelinesRadiopharmaceutical TherapyOncology	2010	295
111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial Irene Virgolini, K. E. Britton, John Buscombe, Seminars in Nuclear Medicine Dna SequencingMedicineGeneticsNext-generation SequencingPathology	2002	237
Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler, BMC Endocrine Disorders	2008	202
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives Clemens Decristoforo, Stephen J. Mather, Witold Cholewiński, European Journal of Nuclear Medicine and Molecular Imaging 111In-labelled Octreotide DerivativesSomatostatin Receptor-positive TumoursNew 99Mtc-labelled RadiopharmaceuticalEngineeringOncologic Imaging	2000	175
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. Michael Gabriel, Clemens Decristoforo, Eveline Donnemiller, PubMed	2003	169
Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease Eveline Donnemiller, Jutta Heilmann, Gregor K. Wenning, European Journal of Nuclear Medicine and Molecular Imaging Neurodegenerative DiseasesLewy Body DiseaseAlzheimer's DiseaseDementiaBiomedical Imaging	1997	166
FDG-PET: procedure guidelines for tumour imaging Emilio Bombardieri, Cumali Aktolun, Richard P. Baum, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyEngineeringOncologic ImagingMedical ImagingPet-mri	2003	94
Low Bone Mineral Density and Impaired Bone Metabolism in Young Alcoholic Patients Without Liver Cirrhosis: A Cross‐Sectional Study Peter Malík, R. Gasser, Georg Kemmler, Alcoholism Clinical and Experimental Research	2008	92
Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. Helga Moncayo, Roy Moncayo, R. Benz, Journal of Clinical Investigation FertilityHormone-receptor ComplexImmunologyReproductive HealthGynecology	1989	91
Incidence and Clinical Characteristics of Thyroid Carcinoma After Iodine Prophylaxis in an Endemic Goiter Country Claudia Bacher-Stier, G Riccabona, Martin Tötsch, Thyroid	1997	91

Page 1